Bloomberg Law
June 1, 2018, 1:03 PM

Right-To-Try Author Says Law’s Intent Is to Diminish FDA’s Power

Anna Edney
Anna Edney
Bloomberg News

Senator Ron Johnson, the chief sponsor of a new law giving terminally ill patients easier access to experimental drugs, said the aim of the measure is to weaken the U.S. Food and Drug Administration.

In a letter to FDA Commissioner Scott Gottlieb on Thursday, the Wisconsin Republican said the goal is to “diminish the FDA’s power over people’s lives, not increase it.”

The blunt message came a day after President Donald Trump signed the so-called right-to-try bill into law. It was in response to previous comments Gottlieb had made detailing how the agency plans to implement the law.

Gottlieb told ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.